Synopsis

Learning Objectives:

•To provide a rationale for the use of WB-MRI when evaluating malignant metastatic disease extent and for therapy response assessments

•To show how measurements are acquired distinguishing between tumor detection (core) and response assessment (comprehensive) protocols that are MET-RADS compliant

•To highlight and review the MET-RADS response assessment criteria and their application

•To illustrate MET-RADS usage with case examples and to provide data on MET-RADS use in clinical practise

•Outline the next steps for MET-RADS development